Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-042168
Filing Date
2017-06-28
Accepted
2017-06-28 18:05:04
Documents
1
Period of Report
2017-06-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5302
  Complete submission text file 0001209191-17-042168.txt   6890
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Issuer) CIK: 0000906709 (see all company filings)

EIN.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DANCE BIOPHARM INC. 150 NORTH HILL DRIVE, SUITE 24 BRISBANE CA 94005
Business Address
Krivulka Joseph J (Reporting) CIK: 0001296750 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-24006 | Film No.: 17936381